ABSTRACT
Background: Diabetes mellitus is the fifth leading cause of death worldwide and is one of the common co-morbid conditions associated with coronary artery disease (CAD). The overall prevalence of CAD is 7.4% but the prevalence of CAD in diabetics is 9%. Hence treatment of hyperglycemia is a key goal of secondary preventive therapy with a target of reducing HbA1c to <7%. The risk of CAD has been reported to occur 2 to3 decades prior in diabetics compared to non-diabetics. Hence discovery of drugs with potential role in both diabetes and CAD seems to be necessary. Ranolazine is a novel oral anti anginal drug known to reduce HbA1c and fasting blood glucose levels in angina patients with diabetes. The objective of this study is to show the effect of ranolazine (antianginal drug) on HbA1c and fasting blood glucose levels in diabetic patients with chronic angina.Methods: Patients were divided into: Group 1 continued with previous antidiabetic drugs and antianginal drugs. Group 2 were prescribed Tab ranolazine 1000mg b.d (orally) as add on therapy along with previous antidiabetic drugs and antianginal drugs.Results: There was a significant reduction in HbA1c and FBS levels in Group 2 patients who were on ranolazine. Reduction of HbA1c in group1 and Group 2 was 0.21�65% and 1.30�16% respectively. Reduction of FBS in group1 and group2 was 10.66�.80mg/dl and 29.97�.49mg/dl respectively.Conclusions: From the present study we can conclude that ranolazine, an antianginal drug when given at a dose of 1000mg bd in diabetic patients with chronic angina reduces HbA1c and FBS levels.
ABSTRACT
Background: Anxiety has become a very important area of research interest in psychopharmacology as it affects one-eighth of the population worldwide. Benzodiazepines are still the most commonly used drugs for anxiety despite a number of side effects.There is a need for newer antianxiety drugs with increased safety and efficacy, hence this study was undertaken to evaluate the anxiolytic activity of Nerium oleander flowers.Methods: Aqueous extract of Nerium oleander flowers (NA) was prepared using soxhalet apparatus. A total of 24 Albino rats aged 8-10 weeks of either sex weighing about 100-150g were obtained and divided into 4 groups of 6 rats each. Group I: Normal saline 10mL/kg. Group II: Diazepam 2mg/kg Group III: NA at a dose of 200 mg/kg Group IV: NA at a dose of 400mg/kg. The anxiolytic activity of Aqueous extract of NA was tested by elevated plus maze and digital actophotometer models. Data was analysed using one way ANOVA followed by Posthoc Tukey’s test.Results: In EPM model, the NA at 200, 400mg/kg doses showed that the number of entries and time spent in the open arms were increased significantly as compared to the control animals. (p<0.001). In Actophoptometer model, two different doses of NA (200 and 400mg/kg) showed a dose-dependent decrease in the locomotor activity, when compared to the control animals (p<0.001).Conclusions: Both the doses of aqueous extract of Nerium oleander flowers (200mg and 400mg/kg) possess anxiolytic activity and could be used as a new approach to treat anxiety.